Nrx pharmaceuticals to present at noble capital markets' 19th annual emerging growth investor conference

Radnor, pa. , nov. 27, 2023 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that dr. jonathan javitt, founder and chief scientist of nrx pharmaceuticals, will present a corporate overview at the noble capital markets' 19th annual emerging growth investor conference on monday, december 4th, 2023, at the college of business executive education building at florida atlantic university in boca raton, fla.
NRXP Ratings Summary
NRXP Quant Ranking